S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Innovator IBD 50 ETF Stock Price, News & Analysis (NYSEARCA:FFTY)

$32.64
+0.13 (+0.40 %)
(As of 10/17/2019 04:00 PM ET)
Add
Today's Range
$32.62
Now: $32.64▼
$32.78
50-Day Range
$31.41
MA: $32.94▼
$34.39
52-Week Range
$25.39
Now: $32.64▼
$36.08
Volume22,673 shs
Average Volume209,473 shs
Market Capitalization$316.63 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Basic Details

Issuer Innovator Capital Management
Fund NameInnovator IBD 50 ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:FFTY
Inception Date4/8/2015
Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkIBD 50 Index
CategoryBroad Equity
FocusBroad Equity
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$315.35 million
Average Daily Volume$136,164.60
Discount/Premium0.00%

ETF Expenses

Management Fee0.70%
Other Expenses0.33%
Total Expenses1.03%
Fee Waiver-0.23%
Net Expenses0.80%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorInnovator Capital Management LLC
CustodianU.S. Bank National Association
DistributorForeside Fund Services, LLC
Transfer AgentU.S. Bancorp Fund Services, LLC
Trustee
Lead Market MakerVirtu Financial
AMEX:FFTY Rates by TradingView

Receive FFTY News and Ratings via Email

Sign-up to receive the latest news and ratings for FFTY and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of Innovator IBD 50 ETF (NYSEARCA:FFTY)
Currency Exposure of Innovator IBD 50 ETF (NYSEARCA:FFTY)
Sector Exposure of Innovator IBD 50 ETF (NYSEARCA:FFTY)
Industry Exposure of Innovator IBD 50 ETF (NYSEARCA:FFTY)

Innovator IBD 50 ETF (NYSEARCA:FFTY) Frequently Asked Questions

What is Innovator IBD 50 ETF's stock symbol?

Innovator IBD 50 ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FFTY."

Has Innovator IBD 50 ETF been receiving favorable news coverage?

Headlines about FFTY stock have been trending very negative on Thursday, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Innovator IBD 50 ETF earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Innovator IBD 50 ETF.

What other stocks do shareholders of Innovator IBD 50 ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innovator IBD 50 ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Universal Display (OLED), Arista Networks (ANET), Applied Materials (AMAT), Activision Blizzard (ATVI), Bank of America (BAC), Twitter (TWTR), Advanced Micro Devices (AMD) and Cisco Systems (CSCO).

Who are Innovator IBD 50 ETF's major shareholders?

Innovator IBD 50 ETF's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Jaffetilchin Investment Partners LLC (0.57%), Intellectus Partners LLC (0.22%), Envestnet Asset Management Inc. (0.17%), Wedbush Securities Inc. (0.14%) and Sterling Investment Advisors Ltd. (0.06%).

Which major investors are selling Innovator IBD 50 ETF stock?

FFTY stock was sold by a variety of institutional investors in the last quarter, including Sterling Investment Advisors Ltd..

Which major investors are buying Innovator IBD 50 ETF stock?

FFTY stock was acquired by a variety of institutional investors in the last quarter, including Wedbush Securities Inc., Envestnet Asset Management Inc., Intellectus Partners LLC and Jaffetilchin Investment Partners LLC.

How do I buy shares of Innovator IBD 50 ETF?

Shares of FFTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innovator IBD 50 ETF's stock price today?

One share of FFTY stock can currently be purchased for approximately $32.64.

How big of a company is Innovator IBD 50 ETF?

Innovator IBD 50 ETF has a market capitalization of $316.63 million. View Additional Information About Innovator IBD 50 ETF.


MarketBeat Community Rating for Innovator IBD 50 ETF (NYSEARCA FFTY)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  82
MarketBeat's community ratings are surveys of what our community members think about Innovator IBD 50 ETF and other stocks. Vote "Outperform" if you believe FFTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FFTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: Return on Investment (ROI)
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel